Allozymes puts its accelerated enzymatics to work on a data and AI play, raising $15M
Allozymes’ ingenious method of quickly testing millions of bio-based chemical reactions is proving to be not just a useful service, but the basis of a unique and valuable dataset. And where there’s a dataset, there’s AI — and where there’s AI, there are investors. The company just raised a $15 million Series A to grow […]
Allozymes puts its accelerated enzymatics to work on a data and AI play, raising $15M Read More »